Genomic Map
Back To TopAssay Details
Target Gene Details
Entrez Gene ID: | 8646 |
Gene Name: | chordin |
Gene Aliases: |
- |
Location: |
Chr.3:184380073-184389835 on Build GRCh38 |
Assay Gene Location: | Within Exon 4 |
| Gene Symbol | Transcript Accession | Exon Location | Assay Transcript Location | Protein ID |
|---|---|---|---|---|
| CHRD | NM_001304472.1 | 3 | 561 | NP_001291401.1 |
| NM_001304473.1 | 4 | 616 | NP_001291402.1 | |
| NM_001304474.1 | 3 | 561 | NP_001291403.1 | |
| NM_003741.3 | 3 | 561 | NP_003732.2 | |
| NR_130747.1 | 3 | 561 | ||
| XM_011513254.1 | 3 | 414 | XP_011511556.1 | |
| XM_011513256.1 | 2 | 202 | XP_011511558.1 | |
| XM_017007388.1 | 3 | 414 | XP_016862877.1 | |
| XM_017007389.1 | 3 | 414 | XP_016862878.1 | |
| XM_017007390.1 | 3 | 414 | XP_016862879.1 | |
| XM_017007391.1 | 3 | 414 | XP_016862880.1 | |
| XM_017007392.1 | 3 | 414 | XP_016862881.1 | |
| XM_017007393.1 | 3 | 414 | XP_016862882.1 | |
| XM_017007394.1 | 2 | 202 | XP_016862883.1 | |
| AB208947.1 | 3 | 334 | BAD92184.1 | |
| AF076612.1 | AAC69835.1 | |||
| AF209928.1 | 3 | 561 | AAG35767.1 | |
| AF209929.1 | 4 | 612 | AAG35768.1 | |
| AF209930.1 | 4 | 616 | AAG35769.1 | |
| AF283325.1 | 3 | 561 | AAG35784.1 | |
| AK074147.1 | 3 | 314 | BAB84973.1 | |
| AK293456.1 | 3 | 283 | ||
| AK295632.1 | 3 | 201 | ||
| AK296316.1 | 2 | 160 | ||
| AY358926.1 | 3 | 451 | AAQ89285.1 | |
| BC112345.1 | 3 | 346 | AAI12346.1 |
Target Copy Number Variation Details
DGV Version: |
Release date: 2016-05-15, GRCh GRCh38 |
| Target Variation |
Location | CNV Subtype |
Genes |
|---|---|---|---|
| esv2422400 | Chr.3:184299495 - 184425713 on Build GRCh38 | Duplication |
 PSMD2
THPO
SNORD66
CHRD
POLR2H
CLCN2
FAM131A
EIF4G1
LOC105374250
|
| nsv829813 | Chr.3:184264997 - 184427996 on Build GRCh38 | Loss |
PSMD2
ECE2
THPO
SNORD66
CHRD
POLR2H
CLCN2
FAM131A
EIF4G1
LOC105374250
|
| nsv511206 | Chr.3:184379999 - 184381418 on Build GRCh38 | Gain |
CHRD
|
Back To TopMore Information
Set Membership: |
Intragenic
Exonic
DGV Variation
|
Gene Ontology Categories:
Back To Top